PROstate Cancer Risk Calculator for ACTionable Clinical Decision-making in Nigeria
Starting soon · Not applicable
Conditions studied: Prostate Cancer, Risk Assessment, Clinical Decision Support Systems, Predictive Value of Tests, Models, Algorithms, Evidence-Based Practice, Implementation Research, Community Health Services, Primary Health Care, Biomarker, Prostate Specific Antigen, Global Health, Africa, Nigeria
In brief
This study is a pilot trial that builds on findings from the validation of prostate cancer risk calculators in Nigerian men. The goal of the overall study is to improve the early detection of prostate cancer in a high-risk population. The main questions the validation study aims to answer are: 1. How accurately do existing prostate cancer risk calculators identify Nigerian men with clinically significant prostate cancer? 2. Will a new risk calculator designed for Nigerian men more accurately identify those with clinically significant prostate cancer? The main questions the intervention study aims to answer is: Will the primary care provider-facing risk calculator be feasible and acceptable for primary care providers to implement? The intervention trial will be piloted among participants in community-level hospitals in order to primarily assess implementation outcomes
Key facts
- Study ID
- NCT07733440
- Run by
- Ahmadu Bello University
- People needed
- 89
- Starts
- 2029-03-01
- Expected to finish
- 2029-08-01
- Last updated by the study team
- 2026-07-29
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: accepted.
You may qualify if…
- Training - Eligible primary care providers (for the training surveys) will be healthcare practitioners at community-level hospitals.
- Supported Risk Assessment
- (i) Eligible key informants will be eligible primary care providers who were trained and implemented the supported risk assessment and the targeted population of patient participants who received the supported risk assessment.
- (ii) Eligible patient participants (for the collection of observation data) will be the target population of adult males 40 - 79 years accessing provider services.
Where it is running
- Ahmadu Bello University Teaching Hospital — Zaria, Kaduna State, Nigeria
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.